Myogen
AcquiredWestminster, United States · Founded 2001
- Headquarters
- Westminster, Colorado
- Employees
- 51–200
- Founded
- 2001
- Business Model
- B2B
- Website
- myogen.com
- Last Round
- Series DAug 2003
- Rounds
- 4
- Acquired by
- GileadOct 2006
About
Myogen was a privately held biopharmaceutical company headquartered in Westminster, Colorado, dedicated to discovering, developing, and commercializing drugs for heart failure and related cardiovascular conditions, including pulmonary arterial hypertension. Founded as a spin-off from the University of Colorado, Myogen advanced two key compounds before being acquired by Gilead Sciences in 2006 for $2.5 billion.
Summary
Myogen is a Biotech company based in Westminster, United States, founded in 2001. Its most recent funding was a Series D round in Aug 2003. Investors include BA Venture Partners, Gilead Sciences and New Enterprise Associates.
Funding & Exit History
Oct 2006
Sign up to see all 6 events
Funding: Series C through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/myogen"><img src="https://indexed.vc/api/badge/company/myogen" alt="Myogen on Indexed.vc" width="260" height="76" /></a>